U.S. Bancorp a un objectif de cours consensuel de $53.33 basé sur les évaluations de 23 analystes. Le plus élevé est $70, publié par Citigroup le octobre 17, 2025. Le plus bas est $42, publié par Jefferies le juillet 3, 2024. Les 3 évaluations d’analystes les plus récentes ont été publiées par TD Cowen, DA Davidson et Citigroup le octobre 20, 2025, octobre 17, 2025 et octobre 17, 2025, respectivement. Avec un objectif de cours moyen de $63 entre TD Cowen, DA Davidson et Citigroup, il existe une variation implicite de 33.76% upside pour U.S. Bancorp selon ces dernières évaluations d’analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/20/2025 | 27.39% | TD Cowen | $59 → $60 | Maintains | Buy | |||
10/17/2025 | 25.27% | DA Davidson | $57 → $59 | Maintains | Buy | |||
10/17/2025 | 48.62% | Citigroup | $65 → $70 | Maintains | Buy | |||
10/17/2025 | 10.4% | Truist Securities | $51 → $52 | Maintains | Hold | |||
10/17/2025 | 10.4% | Wells Fargo | $50 → $52 | Maintains | Overweight | |||
10/17/2025 | 16.77% | B of A Securities | $54 → $55 | Maintains | Buy | |||
10/07/2025 | 6.16% | UBS | $49 → $50 | Maintains | Neutral | |||
09/30/2025 | 14.65% | Evercore ISI Group | $49 → $54 | Maintains | In-Line | |||
09/23/2025 | 40.13% | Oppenheimer | $67 → $66 | Maintains | Outperform | |||
09/19/2025 | 38% | Citigroup | $59 → $65 | Maintains | Buy | |||
09/17/2025 | 8.28% | Truist Securities | $49 → $51 | Maintains | Hold | |||
07/30/2025 | 42.25% | Oppenheimer | $66 → $67 | Maintains | Outperform | |||
07/21/2025 | 10.4% | DA Davidson | $49 → $52 | Maintains | Buy | |||
07/18/2025 | 40.13% | Oppenheimer | $65 → $66 | Maintains | Outperform | |||
07/18/2025 | 10.4% | Morgan Stanley | $51 → $52 | Maintains | Overweight | |||
07/09/2025 | 6.16% | Truist Securities | $48 → $50 | Maintains | Hold | |||
07/07/2025 | 21.02% | Raymond James | $51 → $57 | Upgrade | Outperform → Strong Buy | |||
07/03/2025 | 8.28% | Morgan Stanley | $50 → $51 | Maintains | Overweight | |||
07/02/2025 | 25.27% | Citigroup | $55 → $59 | Maintains | Buy | |||
06/10/2025 | -2.34% | Goldman Sachs | $41 → $46 | Maintains | Neutral | |||
06/04/2025 | 4.03% | Evercore ISI Group | $44 → $49 | Maintains | In-Line | |||
04/28/2025 | -6.58% | Evercore ISI Group | $48 → $44 | Maintains | In-Line | |||
04/28/2025 | 25.27% | Oppenheimer | $57 → $59 | Maintains | Outperform | |||
04/25/2025 | -12.95% | Goldman Sachs | $42 → $41 | Maintains | Neutral | |||
04/17/2025 | 4.03% | DA Davidson | $54 → $49 | Maintains | Buy | |||
04/17/2025 | 8.28% | Raymond James | $57 → $51 | Reiterates | Outperform → Outperform | |||
04/17/2025 | 1.91% | Piper Sandler | $49 → $48 | Maintains | Overweight | |||
04/17/2025 | 6.16% | RBC Capital | $57 → $50 | Maintains | Outperform | |||
04/17/2025 | 6.16% | Morgan Stanley | $51 → $50 | Maintains | Overweight | |||
04/17/2025 | 6.16% | Wells Fargo | $56 → $50 | Maintains | Overweight | |||
04/17/2025 | 18.9% | Barclays | $61 → $56 | Maintains | Overweight | |||
04/17/2025 | 1.91% | Truist Securities | $51 → $48 | Maintains | Hold | |||
04/17/2025 | 4.03% | Keefe, Bruyette & Woods | $54 → $49 | Maintains | Market Perform | |||
04/16/2025 | -10.83% | Goldman Sachs | $44 → $42 | Maintains | Neutral | |||
04/07/2025 | 8.28% | Morgan Stanley | $55 → $51 | Maintains | Overweight | |||
04/04/2025 | 8.28% | Truist Securities | $54 → $51 | Maintains | Hold | |||
04/03/2025 | 4.03% | Wolfe Research | → $49 | Upgrade | Peer Perform → Outperform | |||
04/03/2025 | -7.64% | JP Morgan | $51 → $43.5 | Downgrade | Neutral → Underweight | |||
04/01/2025 | -6.58% | Goldman Sachs | $45 → $44 | Maintains | Neutral | |||
03/28/2025 | 18.9% | Wells Fargo | $62 → $56 | Maintains | Overweight | |||
03/24/2025 | 16.77% | Citigroup | $65 → $55 | Maintains | Buy | |||
03/19/2025 | -4.46% | Goldman Sachs | $51 → $45 | Maintains | Neutral | |||
03/17/2025 | 4.03% | B of A Securities | $50 → $49 | Maintains | Buy | |||
01/17/2025 | 25.27% | Morgan Stanley | $60 → $59 | Maintains | Overweight | |||
01/17/2025 | 33.76% | Oppenheimer | $62 → $63 | Maintains | Outperform | |||
01/07/2025 | 14.65% | Truist Securities | → $54 | Initiates | → Hold | |||
01/06/2025 | 29.51% | Barclays | $57 → $61 | Maintains | Overweight | |||
01/03/2025 | 31.63% | Oppenheimer | $66 → $62 | Maintains | Outperform | |||
01/02/2025 | 27.39% | DA Davidson | $58 → $60 | Upgrade | Neutral → Buy | |||
12/19/2024 | 21.02% | Raymond James | → $57 | Upgrade | Market Perform → Outperform | |||
12/10/2024 | 27.39% | Compass Point | $49 → $60 | Maintains | Buy | |||
12/03/2024 | 23.14% | Piper Sandler | $52 → $58 | Maintains | Neutral | |||
11/25/2024 | 38% | Citigroup | $49 → $65 | Upgrade | Neutral → Buy | |||
11/15/2024 | 31.63% | Wells Fargo | $60 → $62 | Maintains | Overweight | |||
11/05/2024 | 35.88% | Oppenheimer | $59 → $64 | Maintains | Outperform | |||
10/30/2024 | 14.65% | Evercore ISI Group | $51 → $54 | Maintains | In-Line | |||
10/24/2024 | 8.28% | Deutsche Bank | $51 → $51 | Downgrade | Buy → Hold | |||
10/17/2024 | 14.65% | DA Davidson | $49 → $54 | Maintains | Neutral | |||
10/17/2024 | 27.39% | Wells Fargo | $52 → $60 | Maintains | Overweight | |||
10/17/2024 | 21.02% | Barclays | $52 → $57 | Maintains | Overweight | |||
10/17/2024 | 25.27% | Oppenheimer | $57 → $59 | Maintains | Outperform | |||
10/17/2024 | 10.4% | Stephens & Co. | $49 → $52 | Maintains | Equal-Weight | |||
10/02/2024 | 8.28% | Evercore ISI Group | $49 → $51 | Maintains | In-Line | |||
10/02/2024 | 21.02% | Oppenheimer | $54 → $57 | Maintains | Outperform | |||
09/30/2024 | 21.02% | Morgan Stanley | $54 → $57 | Upgrade | Equal-Weight → Overweight | |||
09/13/2024 | 1.91% | RBC Capital | $48 → $48 | Reiterates | Outperform → Outperform | |||
09/11/2024 | -2.34% | Goldman Sachs | $48 → $46 | Maintains | Neutral | |||
07/30/2024 | 14.65% | Morgan Stanley | $47 → $54 | Maintains | Equal-Weight | |||
07/18/2024 | 10.4% | Wells Fargo | $48 → $52 | Maintains | Overweight | |||
07/18/2024 | 4.03% | Citigroup | $45 → $49 | Maintains | Neutral | |||
07/18/2024 | -2.34% | UBS | $43 → $46 | Maintains | Neutral | |||
07/18/2024 | -0.21% | Goldman Sachs | $42 → $47 | Maintains | Neutral | |||
07/18/2024 | 1.91% | RBC Capital | $47 → $48 | Maintains | Outperform | |||
07/18/2024 | 4.03% | DA Davidson | $44 → $49 | Maintains | Neutral | |||
07/03/2024 | -10.83% | Jefferies | $43 → $42 | Maintains | Hold | |||
06/27/2024 | -7.64% | JP Morgan | → $43.5 | Downgrade | Overweight → Neutral | |||
06/25/2024 | 1.91% | Evercore ISI Group | $45 → $48 | Maintains | In-Line | |||
06/21/2024 | -4.46% | Morgan Stanley | $45 → $45 | Maintains | Equal-Weight | |||
05/16/2024 | -0.21% | RBC Capital | $47 → $47 | Reiterates | Outperform → Outperform | |||
05/01/2024 | -7.64% | JP Morgan | $45 → $43.5 | Maintains | Overweight | |||
04/19/2024 | -8.7% | UBS | $47 → $43 | Maintains | Neutral | |||
04/18/2024 | -6.58% | DA Davidson | $45 → $44 | Maintains | Neutral | |||
04/18/2024 | 1.91% | Wells Fargo | $50 → $48 | Maintains | Overweight | |||
04/18/2024 | 10.4% | Barclays | $56 → $52 | Maintains | Overweight | |||
04/18/2024 | -4.46% | Keefe, Bruyette & Woods | $52 → $45 | Downgrade | Outperform → Market Perform | |||
04/18/2024 | 14.65% | Oppenheimer | $55 → $54 | Maintains | Outperform | |||
04/08/2024 | -2.34% | Jefferies | $44 → $46 | Maintains | Hold | |||
04/05/2024 | 10.4% | Keefe, Bruyette & Woods | $50 → $52 | Maintains | Outperform | |||
03/28/2024 | 1.91% | Evercore ISI Group | $46 → $48 | Maintains | In-Line | |||
03/28/2024 | 12.53% | HSBC | $47 → $53 | Upgrade | Hold → Buy | |||
03/22/2024 | 4.03% | Compass Point | $46 → $49 | Upgrade | Neutral → Buy | |||
03/19/2024 | 16.77% | Oppenheimer | $61 → $55 | Maintains | Outperform | |||
01/30/2024 | 29.51% | Oppenheimer | $59 → $61 | Maintains | Outperform | |||
01/30/2024 | -4.46% | Morgan Stanley | $44 → $45 | Maintains | Equal-Weight | |||
01/26/2024 | — | Piper Sandler | — | Downgrade | Overweight → Neutral | |||
01/18/2024 | -0.21% | RBC Capital | $43 → $47 | Maintains | Outperform | |||
01/18/2024 | 25.27% | Oppenheimer | $60 → $59 | Maintains | Outperform | |||
01/02/2024 | 18.9% | Barclays | $48 → $56 | Maintains | Overweight | |||
12/20/2023 | — | Stephens & Co. | — | Downgrade | Overweight → Equal-Weight | |||
12/19/2023 | -10.83% | Goldman Sachs | $37 → $42 | Maintains | Neutral |
Le dernier objectif de prix pour U.S. Bancorp (NYSE:USB) a été rapporté par TD Cowen le octobre 20, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $60.00 s'attendant à ce que USB se rise dans les 12 prochains mois (un possible changement de 27.39% upside). 53 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour U.S. Bancorp (NYSE:USB) a été fournie par TD Cowen, et U.S. Bancorp maintenu leur note buy.
La dernière amélioration pour U.S. Bancorp a eu lieu le juillet 7, 2025 lorsque Raymond James a augmenté leur objectif de prix à $57. Raymond James avait précédemment an outperform pour U.S. Bancorp.
La dernière réduction pour U.S. Bancorp a eu lieu le avril 3, 2025 lorsque JP Morgan a changé leur objectif de prix de $51 à $43.5 pour U.S. Bancorp.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de U.S. Bancorp, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour U.S. Bancorp a été déposée le octobre 20, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 20, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de U.S. Bancorp (USB) était un maintenu avec un objectif de prix de $59.00 à $60.00. Le prix actuel de U.S. Bancorp (USB) est de $47.10, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.